Ataxin-2: From RNA Control to Human Health and Disease
- PMID: 28587229
- PMCID: PMC5485521
- DOI: 10.3390/genes8060157
Ataxin-2: From RNA Control to Human Health and Disease
Abstract
RNA-binding proteins play fundamental roles in the regulation of molecular processes critical to cellular and organismal homeostasis. Recent studies have identified the RNA-binding protein Ataxin-2 as a genetic determinant or risk factor for various diseases including spinocerebellar ataxia type II (SCA2) and amyotrophic lateral sclerosis (ALS), amongst others. Here, we first discuss the increasingly wide-ranging molecular functions of Ataxin-2, from the regulation of RNA stability and translation to the repression of deleterious accumulation of the RNA-DNA hybrid-harbouring R-loop structures. We also highlight the broader physiological roles of Ataxin-2 such as in the regulation of cellular metabolism and circadian rhythms. Finally, we discuss insight from clinically focused studies to shed light on the impact of molecular and physiological roles of Ataxin-2 in various human diseases. We anticipate that deciphering the fundamental functions of Ataxin-2 will uncover unique approaches to help cure or control debilitating and lethal human diseases.
Keywords: ALS; RNA metabolism; RNA-DNA hybrids; SCA2; stress granules.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
R-loops highlight the nucleus in ALS.Nucleus. 2015;6(1):23-9. doi: 10.1080/19491034.2015.1004952. Nucleus. 2015. PMID: 25587791 Free PMC article. Review.
-
Taking a risk: a therapeutic focus on ataxin-2 in amyotrophic lateral sclerosis?Trends Mol Med. 2014 Jan;20(1):25-35. doi: 10.1016/j.molmed.2013.09.001. Epub 2013 Oct 16. Trends Mol Med. 2014. PMID: 24140266 Review.
-
FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion.Acta Neuropathol. 2014 Oct;128(4):597-604. doi: 10.1007/s00401-014-1277-z. Epub 2014 Apr 10. Acta Neuropathol. 2014. PMID: 24718895
-
Genetic ablation of ataxin-2 increases several global translation factors in their transcript abundance but decreases translation rate.Neurogenetics. 2015 Jul;16(3):181-92. doi: 10.1007/s10048-015-0441-5. Epub 2015 Feb 27. Neurogenetics. 2015. PMID: 25721894 Free PMC article.
-
[The function of spinocerebellar ataxia type 2 (SCA2) gene product, ataxin-2 and the mechanism of pathogenesis for SCA2].Nihon Rinsho. 1999 Apr;57(4):822-4. Nihon Rinsho. 1999. PMID: 10222773 Review. Japanese.
Cited by
-
In Cerebellar Atrophy of 12-Month-Old ATM-Null Mice, Transcriptome Upregulations Concern Most Neurotransmission and Neuropeptide Pathways, While Downregulations Affect Prominently Itpr1, Usp2 and Non-Coding RNA.Cells. 2023 Oct 3;12(19):2399. doi: 10.3390/cells12192399. Cells. 2023. PMID: 37830614 Free PMC article.
-
A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS.Front Neurol. 2019 May 14;10:400. doi: 10.3389/fneur.2019.00400. eCollection 2019. Front Neurol. 2019. PMID: 31139131 Free PMC article. Review.
-
Disruption of RNA Metabolism in Neurological Diseases and Emerging Therapeutic Interventions.Neuron. 2019 Apr 17;102(2):294-320. doi: 10.1016/j.neuron.2019.03.014. Neuron. 2019. PMID: 30998900 Free PMC article. Review.
-
Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches.Front Neurol. 2017 Sep 11;8:472. doi: 10.3389/fneur.2017.00472. eCollection 2017. Front Neurol. 2017. PMID: 28955296 Free PMC article. Review.
-
Toxicity of pathogenic ataxin-2 in Drosophila shows dependence on a pure CAG repeat sequence.Hum Mol Genet. 2021 Sep 15;30(19):1797-1810. doi: 10.1093/hmg/ddab148. Hum Mol Genet. 2021. PMID: 34077532 Free PMC article.
References
-
- Imbert G., Saudou F., Yvert G., Devys D., Trottier Y., Garnier J.M., Weber C., Mandel J.L., Cancel G., Abbas N., et al. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat. Genet. 1996;14:285–291. doi: 10.1038/ng1196-285. - DOI - PubMed
-
- Pulst S.M., Nechiporuk A., Nechiporuk T., Gispert S., Chen X.N., Lopes-Cendes I., Pearlman S., Starkman S., Orozco-Diaz G., Lunkes A., et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat. Genet. 1996;14:269–276. doi: 10.1038/ng1196-269. - DOI - PubMed
-
- Sanpei K., Takano H., Igarashi S., Sato T., Oyake M., Sasaki H., Wakisaka A., Tashiro K., Ishida Y., Ikeuchi T., et al. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat. Genet. 1996;14:277–284. doi: 10.1038/ng1196-277. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous